Alternative Routes to Induce Naïve Pluripotency in Human Embryonic Stem Cells

Stem Cells

Volumn 33, Issue 9, 2015, Pages 2686-2698

  Duggal, Galbha ^a   Warrier, Sharat ^a   Ghimire, Sabitri ^a   Broekaert, Dorien ^a,b   Van Der Jeught, Margot ^a   Lierman, Sylvie ^a   Deroo, Tom ^a   Peelman, Luc ^c   Van Soom, Ann ^c   Cornelissen, Ria ^c   Menten, Björn ^a   Mestdagh, Pieter ^a   Vandesompele, Jo ^a   Roost, Matthias ^d   Slieker, Roderick C ^d   Heijmans, Bastiaan T ^d   Deforce, Dieter ^c   De Sutter, Petra ^a   De Sousa Lopes, Susana Chuva ^a,d   Heindryckx, Björn ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b Vesalius Research Center   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Human embryonic stem cells; Na ve; Pluripotency; Signaling; Small molecules

Indexed keywords

ASCORBIC ACID; FIBROBLAST GROWTH FACTOR 2; FORSKOLIN; LONG UNTRANSLATED RNA; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; CONTROLLED STUDY; CULTURE MEDIUM; DNA METHYLATION; EMBRYONIC STEM CELL; FEMALE; GENE; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; KARYOTYPE; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; SIGNAL TRANSDUCTION; SINGLE CELL ANALYSIS; TRANSGENE; UPREGULATION; ANIMAL; C57BL MOUSE; CELL CULTURE; DRUG EFFECTS; HUMAN EMBRYONIC STEM CELL; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; HUMAN EMBRYONIC STEM CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED C57BL; PLURIPOTENT STEM CELLS;

EID: 84940467025     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.2071     Document Type: Article

References (53)

1. Brons IG, Smithers LE, Trotter MW, et al., Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 2007; 448: 191-195.
2. Tesar PJ, Chenoweth JG, Brook FA, et al., New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 2007; 448: 196-199.
3. Evans MJ, Kaufman MH,. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981; 292: 154-156.
4. Nichols J, Smith A,. Naive and primed pluripotent states. Cell Stem Cell 2009; 4: 487-492.
5. Nichols J, Smith A,. The origin and identity of embryonic stem cells. Development 2011; 138: 3-8.
6. Bao S, Tang F, Li X, et al., Epigenetic reversion of post-implantation epiblast to pluripotent embryonic stem cells. Nature 2009; 461: 1292-1295.
7. Zhou H, Li W, Zhu S, et al., Conversion of mouse epiblast stem cells to an earlier pluripotency state by small molecules. J Biol Chem 2010; 285: 29676-29680.
8. Ying Q-L, Wray J, Nichols J, et al., The ground state of embryonic stem cell self-renewal. Nature 2008; 453: 519-U515.
9. Yin R, Mao SQ, Zhao B, et al., Ascorbic Acid enhances tet-mediated 5-methylcytosine oxidation and promotes DNA demethylation in mammals. J Am Chem Soc 2013; 135: 10396-10403.
10. Delghandi MP, Johannessen M, Moens U,. The cAMP signalling pathway activates CREB through PKA, p38 and MSK1 in NIH 3T3 cells. Cell Signal 2005; 17: 1343-1351.
11. Guo G, Yang J, Nichols J, et al., Klf4 reverts developmentally programmed restriction of ground state pluripotency. Development 2009; 136: 1063-1069.
12. Inman GJ, Nicolás FJ, Callahan JF, et al., SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 2002; 62: 65-74.
13. Hanna J, Cheng AW, Saha K, et al., Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc Natl Acad Sci USA 2010; 107: 9222-9227.
14. Gafni O, Weinberger L, Mansour AA, et al., Derivation of novel human ground state naive pluripotent stem cells. Nature 2013; 504: 282-286.
15. Li W, Wei W, Zhu S, et al., Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell 2009; 4: 16-19.
16. Ware CB, Nelson AM, Mecham B, et al., Derivation of naive human embryonic stem cells. Proc Natl Acad Sci USA 2014; 111: 4484-4489.
17. Theunissen TW, Powell BE, Wang H, et al., Systematic identification of culture conditions for induction and maintenance of naive human pluripotency. Cell Stem Cell 2014; 15: 471-487.
18. Takashima Y, Guo G, Loos R, et al., Resetting transcription factor control circuitry toward ground-state pluripotency in human. Cell 2014; 158: 1254-1269.
19. Shamblott MJ, Axelman J, Wang S, et al., Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci USA 1998; 95: 13726-13731.
20. Chan YS, Göke J, Ng JH, et al., Induction of a human pluripotent state with distinct regulatory circuitry that resembles preimplantation epiblast. Cell Stem Cell 2013; 13: 663-675.
21. Valamehr B, Robinson M, Abujarour R, et al., Platform for induction and maintenance of transgene-free hiPSCs resembling ground state pluripotent stem cells. Stem Cell Reports 2014; 2: 366-381.
22. Esteban MA, Wang T, Qin B, et al., Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 2010; 6: 71-79.
23. Siddhanti SR, Hartle JE, Quarles LD,. Forskolin inhibits protein kinase C-induced mitogen activated protein kinase activity in MC3T3-E1 osteoblasts. Endocrinology 1995; 136: 4834-4841.
24. Zhang Y, Li W, Laurent T, et al., Small molecules, big roles-The chemical manipulation of stem cell fate and somatic cell reprogramming. J Cell Sci 2012; 125: 5609-5620.
25. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al., Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145-1147.
26. Greber B, Wu G, Bernemann C, et al., Conserved and divergent roles of FGF signaling in mouse epiblast stem cells and human embryonic stem cells. Cell Stem Cell 2010; 6: 215-226.
27. Duggal G, Heindryckx B, Warrier S, et al., Influence of activin A supplementation during human embryonic stem cell derivation on germ cell differentiation potential. Stem Cells Dev 2013; 22: 3141-3155.
28. Feldman ME, Apsel B, Uotila A, et al., Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2. PLoS Biol 2009; 7: e38.
29. Volders PJ, Helsens K, Wang X, et al., LNCipedia: A database for annotated human lncRNA transcript sequences and structures. Nucleic Acids Res 2013; 41: D246-251.
30. Willems E, Leyns L, Vandesompele J,. Standardization of real-time PCR gene expression data from independent biological replicates. Anal Biochem 2008; 379: 127-129.
31. Aryee MJ, Jaffe AE, Corrada-Bravo H, et al., Minfi: A flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics 2014; 30: 1363-1369.
32. Chen YA, Lemire M, Choufani S, et al., Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics 2013; 8: 203-209.
33. Du P, Kibbe WA, Lin SM,. lumi: A pipeline for processing Illumina microarray. Bioinformatics 2008; 24: 1547-1548.
34. Huang dW, Sherman BT, Lempicki RA,. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4: 44-57.
35. FH, SD, RI et al. Bioconductor-Gviz. [online] Plotting data and annotation information along genomic coordinates. R package version 1.2.1. Available at: http://www.bioconductor.org/packages/release/bioc/html/Gviz.html.
36. Zwaka TP, Thomson JA,. Homologous recombination in human embryonic stem cells. Nat Biotechnol 2003; 21: 319-321.
37. Watanabe K, Ueno M, Kamiya D, et al., A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol 2007; 25: 681-686.
38. Zhou W, Choi M, Margineantu D, et al., HIF1α induced switch from bivalent to exclusively glycolytic metabolism during ESC-to-EpiSC/hESC transition. EMBO J 2012; 31: 2103-2116.
39. Kim K, Doi A, Wen B, et al., Epigenetic memory in induced pluripotent stem cells. Nature 2010; 467: 285-290.
40. Honda A, Hatori M, Hirose M, et al., Naive-like conversion overcomes the limited differentiation capacity of induced pluripotent stem cells. J Biol Chem 2013; 288: 26157-26166.
41. Lengner CJ, Gimelbrant AA, Erwin JA, et al., Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations. Cell 2010; 141: 872-883.
42. Wray J, Kalkan T, Gomez-Lopez S, et al., Inhibition of glycogen synthase kinase-3 alleviates Tcf3 repression of the pluripotency network and increases embryonic stem cell resistance to differentiation. Nat Cell Biol 2011; 13: 838-845.
43. Hassani SN, Totonchi M, Farrokhi A, et al., Simultaneous suppression of TGF-β and ERK signaling contributes to the highly efficient and reproducible generation of mouse embryonic stem cells from previously considered refractory and non-permissive strains. Stem Cell Rev 2012; 8: 472-481.
44. Yamaji M, Ueda J, Hayashi K, et al., PRDM14 ensures naive pluripotency through dual regulation of signaling and epigenetic pathways in mouse embryonic stem cells. Cell Stem Cell 2013; 12: 368-382.
45. Kim DK, Cha Y, Ahn HJ, et al., Lefty1 and lefty2 control the balance between self-renewal and pluripotent differentiation of mouse embryonic stem cells. Stem Cells Dev 2014; 23: 457-466.
46. Yan L, Yang M, Guo H, et al., Single-cell RNA-Seq profiling of human preimplantation embryos and embryonic stem cells. Nat Struct Mol Biol 2013; 20: 1131-1139.
47. Dinger ME, Amaral PP, Mercer TR, et al., Long noncoding RNAs in mouse embryonic stem cell pluripotency and differentiation. Genome Res 2008; 18: 1433-1445.
48. Pekarsky Y, Koval A, Hallas C, et al., Tcl1 enhances Akt kinase activity and mediates its nuclear translocation. Proc Natl Acad Sci USA 2000; 97: 3028-3033.
49. Payer B, Rosenberg M, Yamaji M, et al., Tsix RNA and the germline factor, PRDM14, link X reactivation and stem cell reprogramming. Mol Cell 2013; 52: 805-818.
50. Gillich A, Bao S, Grabole N, et al., Epiblast stem cell-based system reveals reprogramming synergy of germline factors. Cell Stem Cell 2012; 10: 425-439.
51. Graf U, Casanova EA, Cinelli P,. The role of the leukemia inhibitory factor (LIF)-Pathway in derivation and maintenance of murine pluripotent stem cells. Genes (Basel) 2011; 2: 280-297.
52. Vallier L, Touboul T, Chng Z, et al., Early cell fate decisions of human embryonic stem cells and mouse epiblast stem cells are controlled by the same signalling pathways. PLoS One 2009; 4: e6082.
53. Shimizu T, Ueda J, Ho JC, et al., Dual inhibition of Src and GSK3 maintains mouse embryonic stem cells, whose differentiation is mechanically regulated by Src signaling. Stem Cells 2012; 30: 1394-1404.